Investors

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” full_width=”stretch_row” parallax=”content-moving” css=”.vc_custom_1512069349975{padding-top: 10px !important;padding-bottom: 10px !important;background: #eaeaea url(https://www.gbsciences.com/wp-content/uploads/2017/11/Lab_Pic.jpg?id=757) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column width=”1/4″ css=”.vc_custom_1510107442014{padding-left: 80px !important;background-color: #ffffff !important;border-radius: 4px !important;}”][vc_empty_space height=”10px”][vc_custom_heading text=”Investing in Research” font_container=”tag:h2|text_align:left|color:%2300a557″ use_theme_fonts=”yes”][vc_column_text css=”.vc_custom_1598451545948{background-color: #ffffff !important;}”]At GB Sciences, we have two equally important constituencies–the patients who need what we do, and the investors that support what we do. Without the latter, we could not help the former.

 

We continue to explore the leading edge of biomedical research for the development of cannabis-based therapies for the benefit of both constituencies.

 

We encourage investors to read our press releases and public filings. Questions can be emailed to our CFO, Zach Swarts, at zach@gbsciences.com – and welcome aboard![/vc_column_text][vc_btn title=”READ MORE” style=”outline” shape=”round” color=”white” align=”left” link=”||” el_class=”get_my_copy”][/vc_column][vc_column width=”1/2″][/vc_column][vc_column width=”1/4″][vc_empty_space height=”300px”][/vc_column][/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” gap=”10″ equal_height=”yes” content_placement=”bottom”][vc_column width=”1/2″ css=”.vc_custom_1510108653150{background-color: #6e6e6e !important;}”][vc_custom_heading text=”press releases” font_container=”tag:h1|font_size:40|text_align:left|color:%23ffffff” use_theme_fonts=”yes” css=”.vc_custom_1511801889117{padding-top: 40px !important;padding-bottom: 15px !important;}”][vc_column_text]Follow the latest announcements and press coverage about GB Sciences and GBS Global Biopharma.[/vc_column_text][vc_empty_space height=”12px”][vc_btn title=”Learn More” style=”outline” shape=”square” color=”white” link=”url:http%3A%2F%2Fwww.gbsciences.com%2Fpress-releases%2F|||”][/vc_column][vc_column width=”1/2″ css=”.vc_custom_1571172515036{background-color: #0094b9 !important;}”][vc_custom_heading text=”sec filings” font_container=”tag:h1|font_size:40|text_align:left|color:%23ffffff” use_theme_fonts=”yes” css=”.vc_custom_1511801896514{padding-top: 40px !important;padding-bottom: 15px !important;}”][vc_column_text]

Click here for up-to-date reporting to the Securities and
Exchange Commission.

[/vc_column_text][vc_empty_space height=”12px”][vc_btn title=”Learn More” style=”outline” shape=”square” color=”white” link=”url:http%3A%2F%2Fwww.gbsciences.com%2Fsec-filings%2F|title:Learn%20More||”][/vc_column][/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1571171886524{background-color: #878787 !important;}” z_index=””][vc_column][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][vc_empty_space height=”12px”][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row]